Skip to content
DataLookout
Menu

DIIVA-MSNCT06495138

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Oct 2027
    • Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 9 of 9 entries
  2. Notable Eligibility criteria expanded, about 17 words
    • Start date changed from estimate of Apr 2025 to Apr 21, 2025
    • Secondary endpoints: details revised at 1 of 9 entries
    • Study arms: 2 to 3
    v5
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Feb 2025 to Apr 2025
    • Site details revised
    v4
  4. Notable Start date: Sep 2024 to Feb 2025v3
  5. Minor Study description revised
    • Study title shortened, about 3 words
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Composite VOR gain (cVOR gain)
Timeframe: Weeks 0,1,2,3,4,5,6, 7, and 18

Secondary (9)

Best Corrected Dynamic Visual Acuity (During Head Movements)
Balance Evaluation Systems Test Total Score
Gait Disorientation Test (GDT) Score
Dizziness Handicap Inventory Total Score
Activities-specific Balance Confidence Scale Average Score
Show 4 moreShow less
Oscillopsia Visual Analog Scale Score
Disequilibrium Visual Analog Scale Score
Multiple Sclerosis Quality of Life - 54 (MSQOL-54) Total Score
Global Perception of Effect Score

Arms and interventions

Daily Incremental Vestibulo-ocular Reflex Adaptation (D-IVA-GSE)Experimental

The dosages of the D-IVA-GSE and I-IVA-GSE are based on the FITT principle of exercise prescription (frequency, intensity, time, and type). The D-IVA-GSE group will perform two, 15- minute GSE sessions (30-minutes total per day), seven days per week.

Intermittent incremental vestibulo-ocular Reflex Adaptation (I-IVA-GSE)Experimental

The I-IVA-GSE group will perform two, 15-minute IVA-GSE sessions (30 minutes total), three days per week, with at least one day between each exercise day.

Helathy ControlNo intervention

The healthy control group will complete the same baseline assessments as the subjects in the Multiple Sclerosis (MS) group to serve as normative reference data.

Devices: StableEyes

Sites

1 site in 1 country

  • Emory UniveristyAtlanta, Georgia, United States